AUM$1.16B
Expense Ratio0.75%
NAV$28.83
Holdings60
InceptionOct 30, 2014
Price Chart
Key Statistics
Previous Close
$26.17Day Range
$26.12$26.90
52-Week Range
$18.34$34.24
Avg Volume
2.6MDividend Yield
—Expense Ratio
0.75%AUM
$1.16BShares Outstanding
40.3MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 83.12% |
| Switzerland | 10.13% |
| Other | 3.73% |
| United Kingdom | 1.92% |
| Germany | 1.09% |
Fund Information
- Issuer
- ARK
- Category
- Healthcare
- Inception Date
- Oct 30, 2014
- Exchange
- BATS
- Description
- ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
Similar ETFs
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund issued by ARK that launched on Oct 30, 2014. It currently manages $1.16B in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 60 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 59.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | CRSP | CRISPR THERAPEUTICS AG | 9.54% | 2,008,479 | $98.2M |
| 2 | TEM | TEMPUS AI INC-CL A | 9.53% | 1,980,443 | $98.1M |
| 3 | TWST | TWIST BIOSCIENCE CORP | 8.28% | 1,979,293 | $85.1M |
| 4 | TXG | 10X GENOMICS INC-CLASS A | 5.58% | 3,028,626 | $57.4M |
| 5 | BEAM | BEAM THERAPEUTICS INC | 5.27% | 2,118,717 | $54.2M |
| 6 | PSNL | PERSONALIS INC | 4.90% | 7,648,870 | $50.4M |
| 7 | — | NATERA INC | 4.30% | 232,546 | $44.3M |
| 8 | — | ILLUMINA INC | 4.21% | 374,741 | $43.3M |
| 9 | GH | GUARDANT HEALTH INC | 4.04% | 494,819 | $41.6M |
| 10 | RXRX | RECURSION PHARMACEUTICALS-A | 3.83% | 11,972,628 | $39.4M |
| 11 | NTLA | INTELLIA THERAPEUTICS INC | 3.62% | 2,899,319 | $37.3M |
| 12 | CDNA | CAREDX INC | 3.41% | 2,133,205 | $35.1M |
| 13 | VCYT | VERACYTE INC | 3.11% | 1,034,477 | $32.0M |
| 14 | WGS | GENEDX HOLDINGS CORP | 2.54% | 339,906 | $26.1M |
| 15 | — | ABSCI CORP | 2.53% | 11,330,522 | $26.1M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | +0.65% | — | ||
| 1W | -6.93% | — | ||
| 1M | -6.03% | — | ||
| 3M | -12.36% | — | ||
| 6M | +0.93% | — | ||
| YTD | -10.32% | — | ||
| 1Y | +15.03% | — | ||
| 3Y | -11.11% | — | ||
| 5Y | -72.12% | — |
Moving Averages
20-Day MA
$29.32
Below 20-Day MA50-Day MA
$30.30
Below 50-Day MA200-Day MA
$27.17
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$34.24
Current Price
$26.34
52-Week Low
$18.34
$18.34$34.24
Current Yield
—
Annual Dividend
$2.4964
Frequency
1x/year
Last Ex-Date
Dec 29, 2021
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 29, 2021 | $0.3824 | Dec 31, 2021 |
| Dec 29, 2020 | $0.7901 | Dec 31, 2020 |
| Dec 27, 2019 | $1.0539 | Dec 31, 2019 |
| Dec 27, 2018 | $0.2700 | Dec 31, 2018 |
| Dec 27, 2018 | $0.1963 | Dec 31, 2018 |
| Dec 27, 2017 | $0.1927 | Dec 29, 2017 |
| Dec 27, 2017 | $0.1350 | Dec 29, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | ARKG | Healthcare(223 ETFs) | Innovation(5 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.75% | 0.60% | 0.75% |
| AUM | $1.16B | $1.24B | $2.61B |
| Dividend Yield | — | 2.75% | 0.72% |
| Avg Volume | 2.6M | 800.9K | 2.8M |
| Holdings | 60 | 171 | 42 |
| Performance | |||
| 1-Month Return | -10.16% | -4.57% | -3.83% |
| 6-Month Return | +5.61% | +4.90% | -4.99% |
| YTD Return | -9.67% | -1.70% | -8.86% |
| 1-Year Return | +16.57% | +15.18% | +39.67% |
Compare with Another ETF
Search for an ETF to compare with ARKG: